Exclusion of Genetic Information From the Medical Record: Ethical and Medical Dilemmas
JAMA · 01.01.2010
DOI: 10.7916/d8-vat7-0d20 ↗Kurz gefasst
Fachartikel in der Zeitschrift JAMA, erschienen am 01.01.2010. Verfasst von Klitzman und 1 weiteren Autor:innen.
Abstract (Originalsprache)
Increasingly, physicians and patients face dilemmas of whether to exclude genetic information from medical charts, posing critical challenges for practice, research, policy, and education. Physicians and patients are obtaining more genetic information, yet medical records are rapidly becoming electronic, threatening confidentiality. Tensions thus arise between potential medical benefits vs social risks of including information. Use of genetic testing is rapidly increasing through clinicians and direct-to-consumer marketing. Direct-to-consumer tests may be definitive or show only slightly increased disease probabilities, but with advances may have increasing clinical utility. Several institutions have also discussed including whole genome data in medical records. Genetic discrimination has occurred with α1-antitrypsin deficiency, Huntington disease, and other mutations, although the extent remains unclear, partly because such discrimination can be subtle or difficult to prove. Patients may be passed over for promotion or marginalized, but not fired.
Schlagwörter
Zitieren
APA
Klitzman, & L., R. (2010). Exclusion of Genetic Information From the Medical Record: Ethical and Medical Dilemmas. JAMA. https://doi.org/10.7916/d8-vat7-0d20
Vancouver
Klitzman, L. R. Exclusion of Genetic Information From the Medical Record: Ethical and Medical Dilemmas. JAMA. 2010. doi:10.7916/d8-vat7-0d20
BibTeX
@article{Klitzman2010,
author = {Klitzman and L., Robert},
title = {Exclusion of Genetic Information From the Medical Record: Ethical and Medical Dilemmas},
journal = {JAMA},
year = {2010},
doi = {10.7916/d8-vat7-0d20}
}
EUVIMED